Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Humblet

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
Medical Oncology and Tumor Pharmacotherapy|January 1, 1990
Carboplatin in combination with etoposide in inoperable non-small-cell lung cancer (NSCLC)P Weynants, Y Humblet, A Bosly, et al.
Bone Marrow Transplantation|January 1, 1988
Concentration of bone marrow progenitor cells by separation on a Percoll gradient using the Haemonetics model 30Y Humblet, P Lefebvre, J L Jacques, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1990
Interleukin-2 after autologous bone marrow transplantation as consolidative immunotherapy against minimal residual diseaseA Bosly, P Brice, Y Humblet, et al.
European Journal of Cancer & Clinical Oncology|February 1, 1988
Immunodetection of small cell lung cancer metastases in bone marrow using three monoclonal antibodiesJ L Canon, Y Humblet, A M Lebacq-Verheyden, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2008
An open-label study of vandetanib with pemetrexed in patients with previously treated non-small-cell lung cancerR de Boer, Y Humblet, J Wolf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1987
Late intensification chemotherapy with autologous bone marrow transplantation in selected small-cell carcinoma of the lung: a randomized studyY Humblet, M Symann, A Bosly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Multiple courses of high-dose ifosfamide, carboplatin, and etoposide with peripheral-blood progenitor cells and filgrastim for small-cell lung cancer: A feasibility study by the European Group for Blood and Marrow TransplantationS Leyvraz, L Perey, G Rosti, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1989
Carboplatin in association with etoposide and either adriamycin or epirubicin for untreated small cell lung cancer: a dose escalation study of carboplatin. UCL Clinical Oncology GroupY Humblet, P Weynants, A Bosly, et al.
International Journal of Cancer|December 11, 1995
Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3M Marchand, P Weynants, E Rankin, et al.
International Journal of Cancer|November 3, 1995
Expression of MAGE genes in primary and metastatic cutaneous melanomaF Brasseur, D Rimoldi, D Liénard, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Medical Oncology and Tumor Pharmacotherapy|January 1, 1990
Carboplatin in combination with etoposide in inoperable non-small-cell lung cancer (NSCLC)P Weynants, Y Humblet, A Bosly, et al.
Bone Marrow Transplantation|January 1, 1988
Concentration of bone marrow progenitor cells by separation on a Percoll gradient using the Haemonetics model 30Y Humblet, P Lefebvre, J L Jacques, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1990
Interleukin-2 after autologous bone marrow transplantation as consolidative immunotherapy against minimal residual diseaseA Bosly, P Brice, Y Humblet, et al.
European Journal of Cancer & Clinical Oncology|February 1, 1988
Immunodetection of small cell lung cancer metastases in bone marrow using three monoclonal antibodiesJ L Canon, Y Humblet, A M Lebacq-Verheyden, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2008
An open-label study of vandetanib with pemetrexed in patients with previously treated non-small-cell lung cancerR de Boer, Y Humblet, J Wolf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1987
Late intensification chemotherapy with autologous bone marrow transplantation in selected small-cell carcinoma of the lung: a randomized studyY Humblet, M Symann, A Bosly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Multiple courses of high-dose ifosfamide, carboplatin, and etoposide with peripheral-blood progenitor cells and filgrastim for small-cell lung cancer: A feasibility study by the European Group for Blood and Marrow TransplantationS Leyvraz, L Perey, G Rosti, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1989
Carboplatin in association with etoposide and either adriamycin or epirubicin for untreated small cell lung cancer: a dose escalation study of carboplatin. UCL Clinical Oncology GroupY Humblet, P Weynants, A Bosly, et al.
International Journal of Cancer|December 11, 1995
Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3M Marchand, P Weynants, E Rankin, et al.
International Journal of Cancer|November 3, 1995
Expression of MAGE genes in primary and metastatic cutaneous melanomaF Brasseur, D Rimoldi, D Liénard, et al.
Pageof 8